Welcome to our dedicated page for CNO Financial Group SEC filings (Ticker: CNO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on CNO Financial Group's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into CNO Financial Group's regulatory disclosures and financial reporting.
CNO Financial Group submitted a Rule 144 notice reporting the proposed sale of 11,060 common shares.
The filing identifies Scott Goldberg as the holder and lists a stock option exercise with a sale date of 03/20/2026, settlement as cash, and prior sales of 11,060 shares on 03/19/2026 for $442,078.15.
CNO Financial Group reports 2025 results showing a sizable, diversified insurance platform focused on middle‑income pre‑retirees and retirees. As of December 31, 2025, the company had total assets of $38.8 billion, shareholders’ equity of $2.6 billion and revenues of $4.5 billion, generating net income of $229.3 million.
Total 2025 premium collections were $4.5913 billion, led by annuities at $1,943.3 million, health at $1,663.5 million and life at $984.5 million. CNO distributes products through Consumer and Worksite divisions, relies heavily on fixed indexed annuities and supplemental health, and plans to exit Worksite fee services in 2026 to emphasize core insurance operations.
CNO Financial Group General Counsel Matthew J. Zimpfer reported option exercises and related stock sales. On February 17 and 18, 2026, he exercised employee stock options covering 57,370 shares of common stock and acquired the same number of shares through derivative exercises.
On those same dates, he sold a total of 57,370 shares of CNO common stock in open-market transactions at weighted average prices of $43.1656 and $43.0515 per share, pursuant to a Rule 10b5-1 trading plan adopted on June 9, 2025. Following these transactions, he directly owned 307,937 shares of CNO common stock.
CNO Financial Group's Chief Human Resources Officer, Yvonne K. Franzese, sold 9,000 shares of common stock in three open-market transactions on February 17, 2026. The sales were made under a Rule 10b5-1 trading plan adopted on August 20, 2025.
The reported weighted average sale prices were $43.1807, $43.1744 and $43.1638 per share, with individual trades occurring within disclosed ranges between $42.94 and $43.79 per share. Franzese also reports indirect ownership of 78,279 common shares held through the Yvonne K. Franzese Revocable Trust.
CNO Financial Group Chief Executive Officer Gary C. Bhojwani reported open-market sales of company common stock under a pre-arranged Rule 10b5-1 trading plan adopted on August 21, 2025. These trades are designed to execute automatically according to preset instructions rather than day-to-day market timing decisions.
On February 18, 2026, he sold 43,021 shares at a weighted average price of $43.0511 per share, and on February 17, 2026, he sold 45,357 shares at a weighted average price of $43.1657 per share. After these transactions, he held 277,526 shares directly and 635,471 shares indirectly through the Gary C. Bhojwani Revocable Trust.
CNO reported a Form 144 filing indicating the planned sale of 33,800 common shares by the reporting party on 02/18/2026. The filing also lists prior sales by Matthew Zimpfer of 23,570 shares on 02/17/2026 and 30,970 shares on 02/12/2026, reported with their respective aggregate values.
CNO Financial Group reported Form 144 transactions showing insider sales. The filing lists sales by Gary Bhojwani of 45,357 shares for $1,957,866.65 on 02/17/2026, 31,430 shares for $1,319,641.98 on 01/02/2026, and 31,430 shares for $1,256,222.53 on 11/20/2025.
The form also identifies Performance Shares tied to 02/10/2026 under an "ISSUER" designation. The filing is a routine disclosure of proposed or completed sales under resale rules.
An insider of CNO, identified as Matthew Zimpfer, has filed a notice of intent to sell 23,570 common shares through Morgan Stanley Smith Barney LLC, with an aggregate market value of 1,017,413.19. The shares are part of a class with 95,353,512 shares outstanding and are expected to be sold on or about 02/17/2026 on the NYSE.
The shares to be sold were acquired on 02/17/2026 via a stock option exercise from the issuer for cash. Zimpfer also sold 30,970 common shares in a prior transaction on 02/12/2026 for gross proceeds of 1,329,582.36. By signing the notice, the seller represents that he is not aware of any undisclosed material adverse information about the issuer’s operations.
CNO Financial insider Gary Bhojwani filed a notice to sell 45,357 shares of CNO common stock under Rule 144. The planned sale, through Morgan Stanley Smith Barney on the NYSE around 02/17/2026, has an aggregate market value of 1957866.65.
The shares to be sold are performance shares of common stock acquired from the issuer on 02/10/2026. In the past three months, Bhojwanii also sold 31,430 common shares on 01/02/2026 for gross proceeds of 1319641.98 and 31,430 shares on 11/20/2025 for 1256222.53.